Tag Archives: diabetes technology

Continuous glucose monitoring has changed how clinicians and people with diabetes think about glucose control. Yet the next question is more important than whether CGM improves A1C or Time in Range. Can it prevent events that send patients to the emergency department or hospital? Growing evidence suggests that CGM may …

For millions of people who use injectable diabetes medications, treatment can mean living with needles every day. What if a small skin patch could eventually deliver insulin or other therapies with far less discomfort? Researchers studying microneedle patches for diabetes hope to make that possibility practical. These experimental patches use …

Continuous glucose monitors (CGMs) and insulin pumps can transform diabetes management, but the technology only works when patients can comfortably keep wearing it. CGM skin irritation can turn a valuable device into a daily source of itching, redness, pain, or damaged skin. In some cases, the reaction becomes severe enough …

Artificial intelligence is entering diabetes care in a surprisingly quiet way. Rather than appearing as a chatbot or separate decision-support tool, increasingly sophisticated algorithms are being built into automated insulin delivery systems. Adaptive insulin pump hardware can work with continuous glucose monitor (CGM) data, recent insulin delivery, and changing glucose …

Modern diabetes clinical trials look very different from the tightly controlled, site-centered studies clinicians relied on a decade ago. Remote visits, continuous glucose monitoring, wearable sensors, digital data collection, and broader enrollment are changing how evidence is generated. Meanwhile, newer trial designs can make studies more flexible and potentially more …

Many people with type 1 diabetes live with the constant fear of blood glucose dropping too low. Even today’s most advanced automated insulin delivery systems cannot actively raise glucose once levels begin to fall. Instead, they can only reduce or suspend insulin delivery. A dual-hormone artificial pancreas system changes that …

Night-shift work keeps hospitals, factories, transportation systems, and emergency services running around the clock. However, while society benefits from overnight workers, their metabolic health often pays the price. Recent continuous glucose monitoring (CGM) studies have shown that shift work is strongly associated with greater glycemic variability in people with diabetes, …

Every new diabetes medication must prove it is both safe and effective before reaching patients. Traditionally, that process depends on large clinical trials that require thousands of volunteers, years of follow-up, and significant financial investment. However, what if researchers could reduce the number of participants while still producing reliable scientific …

For millions of people living with diabetes, checking blood sugar remains a daily routine that often involves fingersticks or wearing a continuous glucose monitor (CGM) with a tiny sensor inserted beneath the skin. Although CGMs have dramatically improved diabetes management, many people still hope for a truly needle-free alternative. That …

Managing diabetes has never offered more therapeutic options. Continuous glucose monitors (CGMs), automated insulin delivery systems, GLP-1 receptor agonists, SGLT2 inhibitors, and individualized treatment plans have transformed patient care. Yet despite these advances, many people with diabetes continue to struggle, not because treatments are ineffective, but because the overall workload …